Lormatazepam is an orally available benzodiazepine used in the UK for the treatment of short-term insomnia . It is marketed by Auden Mckenzie (Pharma Division) in 0.5 and 1 mg tablet formulations.
For the treatment of short-term insomnia
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.